{"news_desk": "Business", "print_page": "5", "section_name": "Business Day", "subsection_name": null, "byline": {"contributor": "", "original": "By ANDREW POLLACK", "person": [{"rank": 1, "role": "reported", "firstname": "Andrew", "organization": "", "lastname": "POLLACK"}]}, "abstract": "Valeant Pharmaceuticals International says it has received two federal subpoenas connected to its pricing, distribution and patient support practices;  has been criticized for greatly raising prices of its drugs.", "type_of_material": "News", "word_count": "537", "lead_paragraph": "Valeant Pharmaceuticals, which has been criticized for sharp increases in drug prices, said it had received two federal subpoenas.", "pub_date": "2015-10-15T00:00:00Z", "document_type": "article", "slideshow_credits": null, "headline": {"main": "Valeant Under Investigation for Its Drug Pricing Practices", "print_headline": "Valeant Under Investigation for Its Drug Pricing Practices"}, "snippet": "Valeant Pharmaceuticals, which has been criticized for sharp increases in drug prices, said it had received two federal subpoenas.", "multimedia": [{"height": 126, "url": "images/2015/10/02/business/15valeant-web1/02drugprices-web2-thumbWide.jpg", "legacy": {"widewidth": "190", "wideheight": "126", "wide": "images/2015/10/02/business/15valeant-web1/02drugprices-web2-thumbWide.jpg"}, "type": "image", "width": 190, "subtype": "wide"}, {"height": 391, "url": "images/2015/10/02/business/15valeant-web1/02drugprices-web2-articleLarge.jpg", "legacy": {"xlargewidth": "600", "xlargeheight": "391", "xlarge": "images/2015/10/02/business/15valeant-web1/02drugprices-web2-articleLarge.jpg"}, "type": "image", "width": 600, "subtype": "xlarge"}, {"height": 75, "url": "images/2015/10/02/business/15valeant-web1/02drugprices-web2-thumbStandard.jpg", "legacy": {"thumbnailwidth": "75", "thumbnail": "images/2015/10/02/business/15valeant-web1/02drugprices-web2-thumbStandard.jpg", "thumbnailheight": "75"}, "type": "image", "width": 75, "subtype": "thumbnail"}], "web_url": "http://www.nytimes.com/2015/10/15/business/valeant-under-investigation-for-its-drug-pricing-practices.html", "keywords": [{"rank": "1", "is_major": "Y", "value": "Valeant Pharmaceuticals International Inc", "name": "organizations"}, {"rank": "2", "is_major": "Y", "value": "Drugs (Pharmaceuticals)", "name": "subject"}, {"rank": "3", "is_major": "N", "value": "Health Insurance and Managed Care", "name": "subject"}, {"rank": "4", "is_major": "N", "value": "Turing Pharmaceuticals AG", "name": "organizations"}], "blog": [], "_id": "561f20c738f0d81699b2b9df", "source": "The New York Times"}